Foundation Reports
Independent Expert Panel Report on FDA's Human Foods Program
Independent Expert Panel Report on Certain Components of FDA's Tobacco Program
Snapshot 2022: A Changing Environment for FDA-regulated Consumer Products
COVID-19 Real-World Evidence Primer
COVID-19 Lessons Learned: Clinical Evaluation of Therapeutics
A Practical Research Agenda for Treatment Development for Stimulant Use Disorder
Harm Reduction: Clinical Perspectives Summary Report
Harm Reduction: Community Perspectives Summary Report
Payor Perspectives on Substance Use Disorder Treatment
Substance Use Disorder Treatment Journeys Executive Summary
Supporting Healthier Eating in the New Normal: Ultimate Retail Dietician Toolkit
Leveraging Real-World Treatment Experience From Expanded Access Protocols
Journal Articles
Sharing Health Data: The Why, the Will, and the Way Forward
A Special Publication from the National Academy of Medicine, January 2022
2021
Journal Articles
The use of narrative electronic prescribing instructions in pharmacoepidemiology: A scoping review for the International Society for Pharmacoepidemiology Pharmacoepidemiology & Drug Safety
OSE's annual report details Sentinel efforts during COVID pandemic. Regulatory Focus, May 2021
Characteristics Associated with Time-to-Treatment Initiation for Chronic Hepatitis C with New Direct Acting Antivirals. Pharmacoepidemiology & Drug Safety
2020
Journal Articles
FDA Applauds Role of Clinical Trials in Fighting COVID-19. Association of Clinical Research Professionals. Association of Clinical Research Professionals 2020
Validity of an Automated Algorithm to Identify Cirrhosis Using Electronic Health Records in Patients with Primary Biliary Cholangitis. Clinical Epidemiology